Clinical Trial Update: A Study of Azidothymidine in HIV-Infected Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Zidovudine (AZT) in HIV-infected children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalopathy
• HIV Infection

Drugs mentioned

• RETROVIR (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Encephalopathies, HIV Infections | Phase 2 | Status: COMPLETED